Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today announced that Dr. Ivor Royston , President and Chief Executive Officer of Viracta will present at the Oppenheimer 31 st Annual Healthcare Conference taking place virtually from March 16-18, 2021
March 11, 2021
· 1 min read